6.025
price up icon2.99%   0.175
after-market After Hours: 6.02 -0.005 -0.08%
loading
Abivax Adr stock is traded at $6.025, with a volume of 405.69K. It is up +2.99% in the last 24 hours and down -17.13% over the past month. Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.
See More
Previous Close:
$5.85
Open:
$5.93
24h Volume:
405.69K
Relative Volume:
2.79
Market Cap:
$381.78M
Revenue:
-
Net Income/Loss:
$-159.39M
P/E Ratio:
-1.7019
EPS:
-3.5401
Net Cash Flow:
$-105.22M
1W Performance:
+2.12%
1M Performance:
-17.13%
6M Performance:
-44.88%
1Y Performance:
-51.80%
1-Day Range:
Value
$5.88
$6.33
1-Week Range:
Value
$5.55
$6.3499
52-Week Range:
Value
$5.495
$17.02

Abivax Adr Stock (ABVX) Company Profile

Name
Name
Abivax Adr
Name
Phone
-
Name
Address
-
Name
Employee
61
Name
Twitter
Name
Next Earnings Date
2024-12-07
Name
Latest SEC Filings
Name
ABVX's Discussions on Twitter

Compare ABVX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ABVX
Abivax Adr
6.025 381.78M 0 -159.39M -105.22M -3.5401
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
481.16 123.91B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
722.07 78.94B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
657.97 39.98B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
278.25 35.89B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
119.94 28.75B 3.30B -501.07M 1.03B -2.1146

Abivax Adr Stock (ABVX) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-04-24 Initiated JMP Securities Mkt Outperform
Jul-29-24 Initiated Laidlaw Buy
May-20-24 Initiated BTIG Research Buy
Apr-29-24 Initiated Guggenheim Buy
Apr-29-24 Initiated Piper Sandler Overweight
Nov-14-23 Initiated Leerink Partners Outperform
Nov-14-23 Initiated Morgan Stanley Equal-Weight
View All

Abivax Adr Stock (ABVX) Latest News

Abivax Adr Stock (ABVX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):